Williams, Wells Elected To Inovio Biomedical Board
INO | Quote | Chart | News | PowerRating -- (Comment on this article at http://www.financialwire.net/2009/10/27/williams-wells-elected-to-inovio-biomedical-board/)
October 27, 2009 (FinancialWire) -- Inovio Biomedical Corp.'s (AMEX: INO | Quote | Chart | News | PowerRating) (Current Market Cap: $123.19 Mil.) board has elected David J. Williams and Keith H. Wells as directors.
Williams is the former chairman and CEO of Sanofi Pasteur, the vaccine business of Sanofi-Aventis Group. Wells is a senior member of the Biologics Consulting Group and former director of vaccine development for The Salk Institute.
San Diego-based Inovio Biomedical is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases.
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).
http://www.financialwire.net
For full details on Inovio Biomedical Corp (INO) INO. Inovio Biomedical Corp (INO) has Short Term PowerRatings at TradingMarkets. Details on Inovio Biomedical Corp (INO) Short Term PowerRatings is available at This Link.
- Inovio Biomedica Reports Interim Data on Its Cervical Cancer Therapeutic Vaccine - 02/10/10
- Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial - 02/08/10
- Inovio Debuts Skin Electroporation Technology for Delivering DNA Vaccines - 02/04/10
- Inovio Biomedical to Present at BIO CEO & Investor Conference - 02/03/10
- Biotech Stocks to Watch: TPIV, INO, MYGN, CRXL - 02/02/10
- More News >>


